M

Mind Medicine (MindMed)
D

MNMD

8.29500
USD
0.69
(9.07%)
Market Open
Volume
42,337
EPS
-3
Div Yield
-
P/E
-5
Market Cap
606,453,076
Related Instruments
    A
    ATAI
    0.24500
    (17.88%)
    1.61500 USD
    C
    CMPS
    0.13000
    (2.65%)
    5.03000 USD
    C
    CYBN
    0.610
    (5.55%)
    11.610 USD
    T
    TRIP
    -0.645
    (-4.43%)
    13.930 USD
    More
News

Title: Mind Medicine (MindMed)

Sector: Healthcare
Industry: Biotechnology
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.